Broadcast Date: July 7, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Mass spectrometry has been an invaluable tool for laboratory researchers, helping to elucidate the underlying molecular mechanisms of disease. In recent years, reliance on this proven technology has grown, and investigators are putting it to valuable use in clinical settings. Now researchers and clinicians are looking to harness the power of mass spectrometry to understand disease progression and drive the development of treatment therapies. Researchers are optimistic that through the understanding of molecular mechanisms, novel treatment options can be developed for acute and chronic diseases.

In this GEN webinar, Dr. Jenny Van Eyk, of the Cedars-Sinai Medical Center and the Advanced Clinical Biosystems Research Institute, will discuss her most recent data from analytical assays using mass spectrometry for deciphering the precise role that protein expression profiles and modifications play in disease progression. Moreover, she will provide details of the state-of-the-art research facilities at Cedars-Sinai and how it is being utilized daily to aid in research and patient care.

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelist.

 

Produced with support from:
Thermo Fisher logo

 

 

Jennifer Van Eyk, PhD

Jennifer Van Eyk, PhD
Professor of Medicine
Cedars-Sinai Medical Center

The post Mass Spectrometry’s Road from Bench to Bedside appeared first on GEN – Genetic Engineering and Biotechnology News.

Source